[1]CDC: Swine flu viruses in U.S. and Mexico match, CNN, April 25, 2009 — Updated 0437 GMT (1237 HKT)http://edition.cnn.com/2009/HEALTH/04/24/swine.flu/index.html
To see actual statement delivered in the Press Briefing Transcripts, CDC Briefing on Public Health Investigation of Human Cases of Swine Influenza, April 23, 2009, 3:30 p.m. EST, http://www.cdc.gov/media/transcripts/2009/t090423.htm
COX:Thank you very much. The virus that has caused these infections is viruses are actually very interesting. They contain genetic segments as Dr. Schuchat said from four different virus sources.
So we have some gene segments that are North American swine influenza viruses. Some gene segments North American avian influenza viruses. One gene segment from a human influenza virus and two gene segments that are normally found from swine influenza viruses in Asia and in Europe.
[2]More cases of swine flu reported; WHO warns of 'health emergency,' CNN, updated 11:36 p.m. EDT, Sat April 25th, 2009,http://www.cnn.com/2009/HEALTH/04/25/swine.flu/index.html
[4]Influenza A (H1N1): pandemic alert phase 6 declared, of moderate severity, WHO/Europe outbreak update, 11 June 2009, 16:00 GMThttp://www.euro.who.int/influenza/AH1N1/20090611_11
[5]Novartis successfully demonstrates capabilities of cell-based technology for production of A(H1N1) vaccine, Novartis, Media release, June 12, 2009 07:15 CEThttp://www.novartis.com/newsroom/media-releases/en/2009/1322241.shtml
[6]Genetically modified vaccines and foods and their dangers.http://www.responsibletechnology.org/GMFree/AboutGMFoods/FAQs/index.cfm
[11] PubMed.Gov a service of the U.S. Library of Medicine and the National Institute of Health, http://www.ncbi.nlm.nih.gov/pubmed/8473002?dopt=Abstract
[14] Other pandemic influenza vaccines approved by the EMEA (European Medicines Agency) and their ingredients. http://www.emea.europa.eu/htms/human/pandemicinfluenza/vaccines.htm
[15] [CANCERRESEARCH55, 2783-278 July 1, 1995], GM2-KLH Conjugate Vaccine: Increased Immunogenicity in Melanoma Patients after Administration with Immunological Adjuvant QS-21, Friedheim Helling,2 Shengle Zhang, Ann Shang, Sucharita Adluri, Michele Calves, Rao Koganty, B. Michael Longenecker, Tzy-J. Yao, Herbert F. Oettgen, and Philip 0. Livingston
[16]Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders (2002), Board on Health Promotion and Disease Prevention (HPDP), Institute of Medicine (IOM), page 39
[17]Bases for the early immune response after rechallenge or component vaccination in an animal model of acute Mycoplasma pneumoniae pneumonitis, CIMOLAI N. (1) ; MAH D. G. (1) ; TAYLOR G. P. (1) ; MORRISON B. J. (1) ; 1) Division of Medical Microbiology, Department of Pathology, The University of British Columbia, Vancouver, CANADA
[18]Drug Injury, Liability, Analysis and Prevention, Second Edition, James T. O'Donnell, Pharm.D., M.S., FCP, ABCP, FACN, CNS, R.Ph., Chapter 10, Evaluation of Medical Causation, Donald H. Marks, M.D., Ph.D., 10.7. Daibert v. Merrell Dow Pharmaceuticals, Inc., and the Evolution of Causation, Page 148
[19] Vaccines to be administered along with flu vaccines. http://www.fda.gov